Atossa Genetics ROA 2012-2024 | ATOS
Current and historical return on assets (ROA) values for Atossa Genetics (ATOS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Atossa Genetics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $-0.03B | $0.09B | -27.73% |
| 2024-03-31 | $-0.03B | $0.09B | -30.23% |
| 2023-12-31 | $-0.03B | $0.10B | -28.44% |
| 2023-09-30 | $-0.03B | $0.10B | -25.78% |
| 2023-06-30 | $-0.03B | $0.11B | -26.11% |
| 2023-03-31 | $-0.03B | $0.12B | -22.36% |
| 2022-12-31 | $-0.03B | $0.12B | -20.69% |
| 2022-09-30 | $-0.03B | $0.13B | -18.55% |
| 2022-06-30 | $-0.02B | $0.13B | -15.86% |
| 2022-03-31 | $-0.02B | $0.14B | -15.52% |
| 2021-12-31 | $-0.02B | $0.14B | -14.71% |
| 2021-09-30 | $-0.03B | $0.14B | -23.68% |
| 2021-06-30 | $-0.03B | $0.15B | -30.50% |
| 2021-03-31 | $-0.02B | $0.14B | -44.88% |
| 2020-12-31 | $-0.02B | $0.04B | -115.79% |
| 2020-09-30 | $-0.01B | $0.01B | -110.64% |
| 2020-06-30 | $-0.01B | $0.01B | -98.11% |
| 2020-03-31 | $-0.02B | $0.01B | -103.23% |
| 2019-12-31 | $-0.02B | $0.01B | -95.77% |
| 2019-09-30 | $-0.02B | $0.02B | -92.75% |
| 2019-06-30 | $-0.02B | $0.02B | -96.97% |
| 2019-03-31 | $-0.03B | $0.02B | -156.25% |
| 2018-12-31 | $-0.02B | $0.01B | -187.76% |
| 2018-09-30 | $-0.02B | $0.01B | -204.44% |
| 2018-06-30 | $-0.02B | $0.02B | -251.43% |
| 2018-03-31 | $-0.01B | $0.01B | -191.30% |
| 2017-12-31 | $-0.01B | $0.01B | -231.58% |
| 2017-09-30 | $-0.01B | $0.00B | -320.00% |
| 2017-06-30 | $-0.01B | $0.01B | -235.29% |
| 2017-03-31 | $-0.01B | $0.00B | -186.67% |
| 2016-12-31 | $-0.01B | $0.00B | -155.56% |
| 2016-09-30 | $-0.01B | $0.01B | -180.00% |
| 2016-06-30 | $-0.01B | $0.00B | -200.00% |
| 2016-03-31 | $-0.01B | $0.01B | -140.00% |
| 2015-12-31 | $-0.02B | $0.01B | -122.45% |
| 2015-09-30 | $-0.02B | $0.01B | -116.36% |
| 2015-06-30 | $-0.02B | $0.02B | -100.00% |
| 2015-03-31 | $-0.02B | $0.01B | -95.24% |
| 2014-12-31 | $-0.01B | $0.01B | -78.87% |
| 2014-09-30 | $-0.01B | $0.02B | -61.97% |
| 2014-06-30 | $-0.01B | $0.02B | -71.64% |
| 2014-03-31 | $-0.01B | $0.02B | -84.21% |
| 2013-12-31 | $-0.01B | $0.01B | -109.09% |
| 2013-09-30 | $-0.01B | $0.01B | -112.82% |
| 2013-06-30 | $-0.01B | $0.01B | -100.00% |
| 2013-03-31 | $-0.01B | $0.01B | -109.09% |
| 2012-12-31 | $-0.01B | $0.01B | -153.85% |
| 2012-06-30 | $-0.00B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.186B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |